| Basics |
Sensus Healthcare, Inc. Common Stock
Sensus Healthcare Inc is a manufacturer of superficial radiation therapy devices. The Company's products and services include SRT-100, SRT-100 Vision, and Sentinel service program.
|
| IPO Date: |
July 25, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$53.1M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 2.90%
|
| Avg Daily Range (30 D): |
$0.07 | 2.23%
|
| Avg Daily Range (90 D): |
$0.10 | 2.42%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.12M |
| Avg Daily Volume (30 D): |
.07M |
| Avg Daily Volume (90 D): |
.1M |
| Trade Size |
| Avg Trade Size (Sh.): |
135 |
| Avg Trade Size (Sh.) (30 D): |
135 |
| Avg Trade Size (Sh.) (90 D): |
143 |
| Institutional Trades |
| Total Inst.Trades: |
7 |
| Avg Inst. Trade: |
$.74M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$.6M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
78.95K |
|
|
| News |
Oct 9, 2025 @ 5:00 PM
MAREX REMINDER: Bragar Eagel & Squire, P.C. Remind...
Source: Bragar Eagel & Squire, P.C.
|
Oct 9, 2025 @ 4:58 PM
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squi...
Source: Bragar Eagel & Squire, P.C.
|
Oct 9, 2025 @ 4:49 PM
AVITA REMINDER: Bragar Eagel & Squire, P.C. Remind...
Source: Bragar Eagel & Squire, P.C.
|
Aug 31, 2025 @ 12:13 PM
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Inves...
Source: Bragar Eagel & Squire, P.C.
|
Aug 28, 2025 @ 7:43 PM
Sensus Healthcare, Inc. Investors: Company Investi...
Source: Lesley F. Portnoy
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.05
|
$-.06
|
$-.16
|
|
Diluted EPS
|
$-.05
|
$-.06
|
$-.16
|
|
Revenue
|
$ 37.56M
|
$ 7.32M
|
$ 8.34M
|
|
Gross Profit
|
$ 19.6M
|
$ 2.9M
|
$ 4.35M
|
|
Net Income / Loss
|
$ -.85M
|
$ -1.04M
|
$ -2.57M
|
|
Operating Income / Loss
|
$ -1.37M
|
$ -1.94M
|
$ -2.65M
|
|
Cost of Revenue
|
$ 17.96M
|
$ 4.41M
|
$ 3.99M
|
|
Net Cash Flow
|
$ 3.19M
|
$ .11M
|
$ M
|
|
PE Ratio
|
|
|
|
|
|
|